Norman Tsui

Avapecia Life Sciences Corp. is a biotechnology company, which engages in the research, development, and commercialization of regenerative stem cell technologies. It also offers therapy solutions for use in urogynaecology, urology, hair loss, gastrointestinal diseases, respiratory medicine, neurodegenerative diseases, ophthalmology, spinal cord injuries, certain autoimmune diseases, osteoarthritis, medical aesthetics, wound management, and non-healing wounds. The company was founded on January 10, 2014 and is headquartered in Richmond, Canada.

Lohn Caulder LLP provides accounting services.

Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada.

Westshire Capital Ii Corp. engages in the identification and evaluation of companies, assets or businesses with a view to completing a qualifying transaction. The company was founded on June 1, 2015 and is headquartered in Richmond, Canada.

Liberty Biopharma, Inc. develops autologous cell therapy products from adipose tissue to address conditions in the field of female pelvic medicine and reconstructive surgery. The company is headquartered in Richmond, Canada.

Avapecia Life Sciences Corp. is a biotechnology company, which engages in the research, development, and commercialization of regenerative stem cell technologies. It also offers therapy solutions for use in urogynaecology, urology, hair loss, gastrointestinal diseases, respiratory medicine, neurodegenerative diseases, ophthalmology, spinal cord injuries, certain autoimmune diseases, osteoarthritis, medical aesthetics, wound management, and non-healing wounds. The company was founded on January 10, 2014 and is headquartered in Richmond, Canada.

Westshire Capital Ii Corp. engages in the identification and evaluation of companies, assets or businesses with a view to completing a qualifying transaction. The company was founded on June 1, 2015 and is headquartered in Richmond, Canada.

Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada.

Avapecia Life Sciences Corp. is a biotechnology company, which engages in the research, development, and commercialization of regenerative stem cell technologies. It also offers therapy solutions for use in urogynaecology, urology, hair loss, gastrointestinal diseases, respiratory medicine, neurodegenerative diseases, ophthalmology, spinal cord injuries, certain autoimmune diseases, osteoarthritis, medical aesthetics, wound management, and non-healing wounds. The company was founded on January 10, 2014 and is headquartered in Richmond, Canada.

Westshire Capital Ii Corp. engages in the identification and evaluation of companies, assets or businesses with a view to completing a qualifying transaction. The company was founded on June 1, 2015 and is headquartered in Richmond, Canada.

Avapecia Life Sciences Corp. is a biotechnology company, which engages in the research, development, and commercialization of regenerative stem cell technologies. It also offers therapy solutions for use in urogynaecology, urology, hair loss, gastrointestinal diseases, respiratory medicine, neurodegenerative diseases, ophthalmology, spinal cord injuries, certain autoimmune diseases, osteoarthritis, medical aesthetics, wound management, and non-healing wounds. The company was founded on January 10, 2014 and is headquartered in Richmond, Canada.

Liberty Biopharma, Inc. develops autologous cell therapy products from adipose tissue to address conditions in the field of female pelvic medicine and reconstructive surgery. The company is headquartered in Richmond, Canada.

Avapecia Life Sciences Corp. is a biotechnology company, which engages in the research, development, and commercialization of regenerative stem cell technologies. It also offers therapy solutions for use in urogynaecology, urology, hair loss, gastrointestinal diseases, respiratory medicine, neurodegenerative diseases, ophthalmology, spinal cord injuries, certain autoimmune diseases, osteoarthritis, medical aesthetics, wound management, and non-healing wounds. The company was founded on January 10, 2014 and is headquartered in Richmond, Canada.

Acceleware Corp. develops and markets hardware and software acceleration products. The company develops and markets solutions that enable software vendors to leverage heterogeneous, multi core processing hardware without rewriting their applications for parallel computing. The company was founded on February 5, 2004 and is headquartered in Alberta, Canada.

Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada.

Avapecia Life Sciences Corp. is a biotechnology company, which engages in the research, development, and commercialization of regenerative stem cell technologies. It also offers therapy solutions for use in urogynaecology, urology, hair loss, gastrointestinal diseases, respiratory medicine, neurodegenerative diseases, ophthalmology, spinal cord injuries, certain autoimmune diseases, osteoarthritis, medical aesthetics, wound management, and non-healing wounds. The company was founded on January 10, 2014 and is headquartered in Richmond, Canada.

Westshire Capital Ii Corp. engages in the identification and evaluation of companies, assets or businesses with a view to completing a qualifying transaction. The company was founded on June 1, 2015 and is headquartered in Richmond, Canada.

Acceleware Corp. develops and markets hardware and software acceleration products. The company develops and markets solutions that enable software vendors to leverage heterogeneous, multi core processing hardware without rewriting their applications for parallel computing. The company was founded on February 5, 2004 and is headquartered in Alberta, Canada.

Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada.

Avagenesis Corp. engages in the development and commercialization of licensed, patent-pending and patented, automated bioprocessing, and cell-isolation technology for the isolation of regenerative cells from human adipose tissues for use in research and for cosmetic and aesthetic medicine. It uses a proprietary cellular bioprocessing technology. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada.

Acceleware Corp. develops and markets hardware and software acceleration products. The company develops and markets solutions that enable software vendors to leverage heterogeneous, multi core processing hardware without rewriting their applications for parallel computing. The company was founded on February 5, 2004 and is headquartered in Alberta, Canada.

Acceleware Corp. develops and markets hardware and software acceleration products. The company develops and markets solutions that enable software vendors to leverage heterogeneous, multi core processing hardware without rewriting their applications for parallel computing. The company was founded on February 5, 2004 and is headquartered in Alberta, Canada.